Robert Clutter, MD
Family Medicine · Indianapolis, INNPI 1578586277
Payments from drug & device makers
What this record shows
This record is dominated by other: $74,816 of the $77,261 with a category attached, or 96.8%. Stryker accounts for 96.8% of it on its own, with 37 other manufacturers making up the rest. 2024 is the largest year on record at $75,180, more than ten times the $591 reported in 2019. Among family medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $551.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$75K
- Novo Nordisk$348
- AbbVie$287
- AstraZeneca$241
- Amgen$202
- Pfizer$158
- plus $1K from 32 others
What the payments were for
- Speaking & faculty fees$700%
- Food & beverage$2,3753%
- Other$74,81697%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$77,261 in reported general payments places this provider in the 95th percentile of 2,709 family medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 31 | $37,589 |
| MounjaroTirzepatide | 24 | $28,839 |
| OzempicSemaglutide | 20 | $19,566 |
| Bydureon BciseExenatide Microspheres | 12 | $9,757 |
| Atorvastatin Calcium | 202 | $1,809 |
| Metoprolol Succinate | 84 | $1,162 |
| SynthroidLevothyroxine Sodium | 14 | $1,069 |
| Tamsulosin Hcl | 50 | $744 |
| Felodipine ErFelodipine | 13 | $743 |
| Pantoprazole Sodium | 50 | $711 |
| Chlorthalidone | 36 | $647 |
| Omeprazole | 31 | $638 |
| Doxazosin Mesylate | 30 | $594 |
| Lisinopril | 80 | $560 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 44 | $527 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $158 | $37,58931 claims |
| Lilly USA, LLCMounjaro | $102 | $28,83924 claims |
| Novo NordiskOzempic | $348 | $19,56620 claims |
| AbbVieSynthroid | $287 | $1,06914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Indianapolis
- Richard TannerIndianapolis$1.6M
- Richard FeldmanIndianapolis$476K
- Joe BanksIndianapolis$294K
- Jakoda SniderIndianapolis$107K
- Blair BrengleIndianapolis$17K
- James AndryBloomington$715K
- Anthony InzerelloEvansville$308K
- Steven GatewoodElwood$281K
- Shekar PushpalaCarmel$239K
- Victoria MoyerKokomo$188K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.